Patent Application Titled "Inhaled Statins For Treatment Of Viral Respiratory Diseases" Published Online (USPTO 20230172849).

Předmět:
Zdroj: Medical Letter on the CDC & FDA; 6/30/2023, p2819-2819, 1p
Abstrakt: The method of any one of claims 27 to 33, wherein the viral respiratory infection is selected from the group consisting of a coronavirus, a morbillivirus, a bunyavirus, an arenavirus, an influenza, a rhinovirus, and an adenovirus. The method of claim 1, wherein the viral respiratory infection is selected from the group consisting of a coronavirus, a morbillivirus, a bunyavirus, an arenavirus, an influenza, a rhinovirus, and an adenovirus. "In some embodiments, the present invention provides a method for blocking viral entry into a cell comprising administering a therapeutically effective amount of a statin, and wherein the virus is a SARS virus.". [Extracted from the article]
Databáze: Complementary Index